Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADXN
DateTimeSourceHeadlineSymbolCompany
03/29/20227:30AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ADXNAddex Therapeutics Ltd
03/24/20222:00AMGlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth ConferencesNASDAQ:ADXNAddex Therapeutics Ltd
03/10/20226:10AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADXNAddex Therapeutics Ltd
03/10/20226:09AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ADXNAddex Therapeutics Ltd
03/10/20221:10AMGlobeNewswire Inc.Addex Reports Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
03/07/20221:00AMGlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2021 Financial Results and Host Conference Call on March 10, 2022NASDAQ:ADXNAddex Therapeutics Ltd
02/24/20221:00AMGlobeNewswire Inc.Addex to Present at the Virtual Sachs Associates 3rd Annual European HealthTech and 15th Annual European Life Sciences CEO ForumsNASDAQ:ADXNAddex Therapeutics Ltd
02/18/20224:55PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADXNAddex Therapeutics Ltd
02/15/20226:56AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADXNAddex Therapeutics Ltd
02/14/20224:46PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADXNAddex Therapeutics Ltd
02/14/20223:33PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADXNAddex Therapeutics Ltd
02/14/20221:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADXNAddex Therapeutics Ltd
02/03/20221:00AMGlobeNewswire Inc.Addex Increases Issued Share Capital to Create Treasury SharesNASDAQ:ADXNAddex Therapeutics Ltd
01/19/20226:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADXNAddex Therapeutics Ltd
01/19/20226:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADXNAddex Therapeutics Ltd
01/11/20221:00AMGlobeNewswire Inc.Addex to Present at the Swiss Equities Baader Virtual ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
01/10/20221:15PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADXNAddex Therapeutics Ltd
01/07/20224:12PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:ADXNAddex Therapeutics Ltd
01/06/20221:00AMGlobeNewswire Inc.Addex to Present at the H.C. Wainwright BIOCONNECT Virtual ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
12/21/20214:53PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADXNAddex Therapeutics Ltd
12/20/20216:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADXNAddex Therapeutics Ltd
12/17/20211:00AMGlobeNewswire Inc.Addex Raises $10.0 Million in Equity FinancingNASDAQ:ADXNAddex Therapeutics Ltd
12/15/20219:39AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADXNAddex Therapeutics Ltd
12/15/20211:00AMGlobeNewswire Inc.Addex Provides Year End Pipeline Development UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/18/20211:00AMGlobeNewswire Inc.Addex to Present at the Virtual German Equity ForumNASDAQ:ADXNAddex Therapeutics Ltd
11/15/20211:00AMGlobeNewswire Inc.Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149NASDAQ:ADXNAddex Therapeutics Ltd
11/15/20211:00AMGlobeNewswire Inc.Addex to Present at the H.C. Wainwright 7th Annual Israel Virtual ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
11/04/20217:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ADXNAddex Therapeutics Ltd
11/04/20212:00AMGlobeNewswire Inc.Addex Reports Q3 2021 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/01/20212:00AMGlobeNewswire Inc.Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on November 4, 2021NASDAQ:ADXNAddex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ADXN